Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.4 - $4.27 $1,333 - $14,231
3,333 Added 0.8%
420,973 $166,000
Q2 2022

Aug 12, 2022

SELL
$0.56 - $1.29 $1,193 - $2,748
-2,131 Reduced 0.51%
417,640 $235,000
Q1 2022

May 13, 2022

BUY
$0.72 - $1.86 $53,092 - $137,154
73,739 Added 21.31%
419,771 $470,000
Q4 2021

Feb 11, 2022

BUY
$1.3 - $3.17 $35,566 - $86,728
27,359 Added 8.59%
346,032 $505,000
Q3 2021

Nov 12, 2021

BUY
$2.91 - $4.5 $36,165 - $55,926
12,428 Added 4.06%
318,673 $956,000
Q2 2021

Aug 13, 2021

SELL
$4.15 - $6.3 $1.03 Million - $1.57 Million
-248,870 Reduced 44.83%
306,245 $1.42 Million
Q1 2021

May 12, 2021

BUY
$5.51 - $9.42 $478,532 - $818,108
86,848 Added 18.55%
555,115 $3.33 Million
Q4 2020

Feb 12, 2021

BUY
$3.42 - $6.36 $60,841 - $113,144
17,790 Added 3.95%
468,267 $2.45 Million
Q3 2020

Nov 13, 2020

SELL
$2.94 - $12.43 $44,329 - $187,419
-15,078 Reduced 3.24%
450,477 $1.56 Million
Q2 2020

Aug 13, 2020

BUY
$5.28 - $9.67 $337,302 - $617,748
63,883 Added 15.9%
465,555 $4.04 Million
Q1 2020

May 14, 2020

BUY
$5.0 - $7.6 $226,615 - $344,454
45,323 Added 12.72%
401,672 $2.33 Million
Q4 2019

Feb 13, 2020

BUY
$5.99 - $8.38 $167,420 - $234,221
27,950 Added 8.51%
356,349 $2.57 Million
Q3 2019

Nov 12, 2019

BUY
$5.62 - $9.63 $716,527 - $1.23 Million
127,496 Added 63.46%
328,399 $2 Million
Q2 2019

Aug 14, 2019

BUY
$7.59 - $10.21 $242,925 - $326,781
32,006 Added 18.95%
200,903 $1.91 Million
Q1 2019

May 14, 2019

BUY
$7.65 - $16.66 $179,078 - $389,993
23,409 Added 16.09%
168,897 $1.37 Million
Q4 2018

Feb 13, 2019

BUY
$10.76 - $17.25 $941,704 - $1.51 Million
87,519 Added 150.98%
145,488 $2.37 Million
Q3 2018

Nov 13, 2018

BUY
$14.34 - $22.97 $24,119 - $38,635
1,682 Added 2.99%
57,969 $944,000
Q2 2018

Aug 14, 2018

BUY
$12.76 - $16.94 $718,222 - $953,501
56,287 New
56,287 $847,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0

About Unity Biotechnology, Inc.


  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $20.6M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.